Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $497.31 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $261.52 | 7 | $0 (2022) |
| Daiichi Sankyo Inc. | $125.43 | 6 | $0 (2023) |
| BOSTON SCIENTIFIC CORPORATION | $110.36 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $25.32 | 1 | Daiichi Sankyo Inc. ($25.32) |
| 2022 | $49.85 | 2 | ABBVIE INC. ($49.85) |
| 2021 | $55.25 | 2 | AbbVie Inc. ($55.25) |
| 2019 | $74.05 | 1 | AbbVie, Inc. ($74.05) |
| 2018 | $200.92 | 8 | Daiichi Sankyo Inc. ($100.11) |
| 2017 | $91.92 | 1 | BOSTON SCIENTIFIC CORPORATION ($91.92) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/23/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Iron Deficiency Anemia | ||||||
| 04/13/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/10/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/03/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $39.82 | General |
| 11/02/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/02/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $74.05 | General |
| 11/06/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $58.80 | General |
| Category: Immunology | ||||||
| 10/29/2018 | BOSTON SCIENTIFIC CORPORATION | GENERAL BIOPSY (Device) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: BIOPSY | ||||||
| 08/27/2018 | Daiichi Sankyo Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Opioid Induced Constipation | ||||||
| 08/23/2018 | Daiichi Sankyo Inc. | Morphabond ER (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Pain Management | ||||||
| 07/11/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $23.57 | General |
| 05/11/2018 | Daiichi Sankyo Inc. | Morphabond ER (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Pain Management | ||||||
| 03/06/2018 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Anemia | ||||||
| 01/22/2018 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Anemia | ||||||
| 11/03/2017 | BOSTON SCIENTIFIC CORPORATION | GENERAL - THERAPIES (Device) | Food and Beverage | In-kind items and services | $91.92 | General |
| Category: THERAPIES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 509 | 530 | $987,966 | $56,607 |
| 2022 | 16 | 645 | 698 | $1.2M | $69,211 |
| 2021 | 15 | 684 | 739 | $1.1M | $77,175 |
| 2020 | 15 | 637 | 689 | $1.1M | $68,809 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 130 | 130 | $390,750 | $22,980 | 5.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 46 | 46 | $118,390 | $7,321 | 6.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 61 | 62 | $174,681 | $6,004 | 3.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 49 | $12,642 | $3,913 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 68 | $14,416 | $3,791 | 26.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 74 | 75 | $154,575 | $3,681 | 2.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 17 | 17 | $43,639 | $2,707 | 6.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $9,960 | $1,849 | 18.6% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 17 | 17 | $35,037 | $1,276 | 3.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $6,608 | $1,105 | 16.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 18 | $4,392 | $1,001 | 22.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $22,876 | $979.43 | 4.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 126 | 126 | $367,416 | $21,964 | 6.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 62 | 62 | $154,504 | $10,000 | 6.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 74 | 74 | $202,020 | $7,619 | 3.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 95 | 98 | $196,098 | $5,524 | 2.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 71 | $14,555 | $3,904 | 26.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 36 | 73 | $17,228 | $3,708 | 21.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 26 | 26 | $14,690 | $3,675 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 39 | 44 | $11,000 | $3,635 | 33.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $9,177 | $1,940 | 21.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 12 | 12 | $29,904 | $1,873 | 6.3% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 14 | 14 | $28,014 | $1,354 | 4.8% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 12 | 12 | $24,012 | $1,301 | 5.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $7,038 | $1,202 | 17.1% |
About Dr. David Carron, MD
Dr. David Carron, MD is a Gastroenterology healthcare provider based in Milwaukee, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023085487.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Carron, MD has received a total of $497.31 in payments from pharmaceutical and medical device companies, with $25.32 received in 2023. These payments were reported across 15 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($497.31).
As a Medicare-enrolled provider, Carron has provided services to 2,475 Medicare beneficiaries, totaling 2,656 services with total Medicare billing of $271,803. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Milwaukee, WI
- Active Since 03/03/2006
- Last Updated 01/26/2026
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1023085487
Products in Payments
- GENERAL - THERAPIES (Device) $91.92
- LINZESS (Drug) $65.28
- INJECTAFER (Drug) $64.50
- Humira (Biological) $58.80
- Morphabond ER (Drug) $37.90
- Movantik (Drug) $23.03
- GENERAL BIOPSY (Device) $18.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Milwaukee
Dr. Poonam Beniwal-Patel, M.d, M.D
Gastroenterology — Payments: $113,855
Dr. Matthew Peller, Md, MD
Gastroenterology — Payments: $63,065
Chetan Mittal, Md, MD
Gastroenterology — Payments: $54,638
Dr. Kulwinder Dua, Md, MD
Gastroenterology — Payments: $37,112
Dr. Zachary Smith, Do, DO
Gastroenterology — Payments: $30,612
Nalini Guda, Md, MD
Gastroenterology — Payments: $28,130